1. Home
  2. ENZ vs ANEB Comparison

ENZ vs ANEB Comparison

Compare ENZ & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENZ
  • ANEB
  • Stock Information
  • Founded
  • ENZ 1976
  • ANEB 2020
  • Country
  • ENZ United States
  • ANEB United States
  • Employees
  • ENZ N/A
  • ANEB N/A
  • Industry
  • ENZ Medical Specialities
  • ANEB Biotechnology: Pharmaceutical Preparations
  • Sector
  • ENZ Health Care
  • ANEB Health Care
  • Exchange
  • ENZ Nasdaq
  • ANEB Nasdaq
  • Market Cap
  • ENZ 34.2M
  • ANEB 36.7M
  • IPO Year
  • ENZ N/A
  • ANEB 2021
  • Fundamental
  • Price
  • ENZ $0.52
  • ANEB $1.53
  • Analyst Decision
  • ENZ
  • ANEB Buy
  • Analyst Count
  • ENZ 0
  • ANEB 1
  • Target Price
  • ENZ N/A
  • ANEB $8.00
  • AVG Volume (30 Days)
  • ENZ 180.8K
  • ANEB 12.3K
  • Earning Date
  • ENZ 03-12-2025
  • ANEB 02-14-2025
  • Dividend Yield
  • ENZ N/A
  • ANEB N/A
  • EPS Growth
  • ENZ N/A
  • ANEB N/A
  • EPS
  • ENZ N/A
  • ANEB N/A
  • Revenue
  • ENZ $30,314,000.00
  • ANEB N/A
  • Revenue This Year
  • ENZ N/A
  • ANEB N/A
  • Revenue Next Year
  • ENZ N/A
  • ANEB N/A
  • P/E Ratio
  • ENZ N/A
  • ANEB N/A
  • Revenue Growth
  • ENZ N/A
  • ANEB N/A
  • 52 Week Low
  • ENZ $0.41
  • ANEB $0.80
  • 52 Week High
  • ENZ $1.40
  • ANEB $3.30
  • Technical
  • Relative Strength Index (RSI)
  • ENZ 35.40
  • ANEB 51.53
  • Support Level
  • ENZ $0.46
  • ANEB $1.45
  • Resistance Level
  • ENZ $0.57
  • ANEB $1.56
  • Average True Range (ATR)
  • ENZ 0.05
  • ANEB 0.15
  • MACD
  • ENZ 0.00
  • ANEB -0.01
  • Stochastic Oscillator
  • ENZ 49.14
  • ANEB 47.73

About ENZ Enzo Biochem Inc. ($0.01 Par Value)

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Share on Social Networks: